Good day. Dominic Barfield here and this is the RVC Clinical Podcast. Thank you for listening

and thank you for subscribing on your smartphone or generic fruit-based device. We're really

grateful for you taking the time to download and listen to this RVC podcast. We don't ask for

anything in turn. Well, not at the moment at least. They would be incredibly grateful if you

go pop to Apple podcast or iTunes or even ACOTS where we're now on and leave us for review.

So obviously a five-star review would be great and we'll probably try and read out some reviews

in the next couple of podcasts that we do.

So if you could spend your time and do that, that would be fantastic.

So today we're joined again by Professor Jill Madsen. Thank you very much, Jill,

for coming back in and having a chat. Thank you, Joel. And I thought what we could talk about

is this like canine pancreatic specific lipase. And I suppose more specifically where you think

it should be used or is clinically useful and maybe where, you know, and how you use it in practice.

Okay, that's a fairly open question.

Is it okay if we also talk about feline as well?

Yeah, absolutely.

Or we're just going to be doggist?

No, we can, we can, we don't have to be speciesists.

Okay, all right, okay.

So I think, as you know, the pancreatic lipase immunoreactivity test has been around for a few years now and was launched and is it, you know, addition to our sort of range of tests that we've got in the diagnosis of pancreatitis.

And I think as we all recognize as well, pancreatitis in dogs and cats is different.

And we've got more likely to have acute pancreatitis in dogs,

although chronic pancreatitis has been recognised,

...